Sensus Healthcare (SRTS) Director Eric Sachetta Buys 31,000 Shares

What Happened Eric Sachetta, a director of Sensus Healthcare, purchased shares in two open-market transactions: 24,000 shares on 2026-08-20 at $3.13 (reported value $75,072) and 7,000 shares on 2026-08-21 at $3.25 (reported value $22,778). These were purchases (transaction code P), representing a total acquisition of 31,000 shares for approximately $97,850. Purchases by insiders can be seen by some investors as a more informative (bullish) signal than routine sales, though this filing does not state the insider’s motivation.

Key Details

• Transaction dates and prices: 2026-08-20 — 24,000 shares @ $3.13 (reported $75,072); 2026-08-21 — 7,000 shares @ $3.25 (reported $22,778).
• Total purchased: 31,000 shares; total reported value ≈ $97,850.
• Transaction type: Open-market purchases (code P).
• Shares owned after transaction: Not specified in the information provided.
• Footnotes/plans: No 10b5-1 plan, tax withholding, or other footnotes noted in the summary provided.
• Filing timeliness: Form 4 filed 2026-08-24 for trades on Aug 20–21; this appears to be within the SEC’s two-business-day reporting window.

Context These were straightforward open-market purchases by a company director (not an option exercise, gift, or tax withholding). For retail investors, insider buys are often watched as a potential positive signal, but they should be considered alongside company fundamentals and other information before drawing investment conclusions.